Skip to main content
Equibles

Aziz Sawaf

CFO

Theravance Biopharma, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Aziz Sawaf

Aziz Sawaf is recorded as CFO at Theravance Biopharma, Inc.. Theravance Biopharma, Inc. reported in an 8-K filed December 12, 2022 that Aziz Sawaf was appointed Chief Financial Officer, effective December 31, 2022. Aziz Sawaf has spoken on 12 earnings calls across 1 company, most recently for Theravance Biopharma, Inc. on November 10, 2025.

“The Company has appointed Aziz Sawaf, CFA as the Company's Chief Financial Officer, effective immediately following Mr. Hindman's departure.”
Theravance Biopharma, Inc. Form 8-K, filed December 12, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Theravance Biopharma, Inc.

    CFO

    Proxy statement

    Current

    Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Theravance Biopharma, Inc.

Current role

CFO

12 appearances Latest appearance 2025-11-10

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2022 Earnings Call

    Theravance Biopharma, Inc.

Show 1 earlier activities